BRIEF published on 01/27/2026 at 18:05, 4 months 25 days ago Bilan semestriel du contrat de liquidité de Theranexus Contrat De Liquidité PORTZAMPARC Bilan Financier Theranexus Actions THX Pharma
PRESS RELEASE published on 01/27/2026 at 18:00, 4 months 25 days ago BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC THX Pharma publie le bilan semestriel de son contrat de liquidité confié à Portzamparc. Détails des titres et montants du compte de liquidité au 31/12/2025 Contrat De Liquidité Bilan Semestriel PORTZAMPARC Maladies Neurologiques Rares THX Pharma
BRIEF published on 01/20/2026 at 18:05, 5 months 1 day ago THX Pharma dévoile son calendrier financier 2026 Euronext Paris Agenda Financier Biopharmaceutique 2026 THX Pharma
BRIEF published on 01/20/2026 at 18:05, 5 months 1 day ago THX Pharma Reveals 2026 Financial Schedule Financial Calendar Neurological Diseases Market Communication 2026 Announcements THX Pharma
BRIEF published on 01/20/2026 at 18:05, 5 months 1 day ago THX Pharma dévoile son calendrier financier pour 2026 Calendrier Financier Maladies Neurologiques THX Pharma Annonces De 2026 Communication Marketing
BRIEF published on 01/20/2026 at 18:05, 5 months 1 day ago THX Pharma unveils its 2026 financial calendar Euronext Paris Financial Agenda Biopharmaceutical 2026 THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 5 months 1 day ago THX Pharma publie son agenda financier 2026 THX Pharma publie son agenda financier 2026, incluant les dates de communication financière et informations sur ses médicaments innovants. Retrouvez plus d'informations sur http://www.theranexus.com Communication Financière Agenda Financier Médicaments Neurologiques Rares THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 5 months 1 day ago THX Pharma Announces its 2026 Financial Calendar THX Pharma (Theranexus) announces financial communication agenda for 2026, focusing on rare neurological diseases treatments. Company listed on Euronext Growth Paris Euronext Growth Paris Financial Communication Theranexus Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 5 months 13 days ago THX Pharma Releases Shareholder Letter Drug Development Biopharmaceutical Shareholder Communication Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 5 months 13 days ago Publication of the letter to shareholders by Theranexus Shareholders Neuroscience Rare Diseases Theranexus Drugs
Published on 06/22/2026 at 11:00, 47 minutes ago American Critical Minerals Mobilizes to the Green River Project to Commence Drill Pad Construction
Published on 06/22/2026 at 09:01, 2 hours 46 minutes ago Apex Drills 14.9 m of 5.09 % REO and 12.3 m of 5.63 % REO with > 2.50 % REO Intercept Over 191.9 m in the Trinity Zone at the Rift Rare Earth Project
Published on 06/20/2026 at 01:00, 2 days 10 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 11 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/22/2026 at 11:05, 41 minutes ago Hisense Showcases "Innovating a Brighter Life" Message at FIFA World Cup 2026™
Published on 06/22/2026 at 11:00, 46 minutes ago Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Published on 06/22/2026 at 10:55, 51 minutes ago Envision Energy Unveils 2026 Net Zero Action Report at VivaTech, Pioneering Future Energy Systems for Civilizational Prosperity
Published on 06/22/2026 at 08:30, 3 hours 17 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 3 hours 17 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 16 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 16 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 16 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
